A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose

A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and

Inhibition of ADAMTS-5 endocytosis by 1B7. (A) Human chondrocytes

A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and

A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and

Rigidified Bis(sulfonyl)ethylenes as Effective Michael Acceptors

From DEL Selections to Validated Hits to Clinical Leads

Recent Research Advances in Selective Matrix Metalloproteinase‐13

Aggrecan in Cardiovascular Development and Disease - Christopher D

Coronary Disease Association With ADAMTS7 Is Due to Protease

Pharmacological characterization of GLPG1972/S201086, a potent and

Drug Insight: aggrecanases as therapeutic targets for

Aggrecanases and cartilage matrix degradation

PDF) Discovery of GLPG1972/S201086, a Potent, Selective, and

Full article: Advances in the development of novel aggrecanase

A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and